Provided by Tiger Fintech (Singapore) Pte. Ltd.

Medtronic PLC

84.18
-0.4250-0.50%
Volume:1.14M
Turnover:95.77M
Market Cap:107.96B
PE:25.74
High:85.00
Open:84.77
Low:83.68
Close:84.60
Loading ...

Medtronic Education Program Opens Doors for Employees

ACCESS Newswire
·
3 hours ago

Medtronic Unveils Promising Sacral Neuromodulation Study for Overactive Bladder at AUA 2025 Annual Meeting

Reuters
·
21 hours ago

The Zacks Analyst Blog Highlights Abbott Laboratories, Boston Scientific and Medtronic

Zacks
·
28 Apr

Medtronic announces Expand URO IDE study met primary safety, effective endpoint

TIPRANKS
·
28 Apr

Medtronic announces outcomes from two studies in AFib patients

TIPRANKS
·
28 Apr

BRIEF-Medtronic PLC Says Sphere-360 Study Shows 88% Freedom From Arrhythmia Recurrence

Reuters
·
27 Apr

Medtronic Plc - Sphere-360 Study Shows 88% Freedom From Arrhythmia Recurrence

THOMSON REUTERS
·
27 Apr

Medtronic Affera™ pulsed field ablation technologies continue to demonstrate promising evidence for atrial fibrillation patients

PR Newswire
·
27 Apr

Medtronic Expand Uro U.S. Clinical Trial Meets Safety And Effectiveness Primary Endpoints For Hugo™ Robotic-Assisted Surgery System

Reuters
·
27 Apr

Medtronic Plc - Submits Hugo Ras System to U.S. FDA

THOMSON REUTERS
·
27 Apr

Medtronic Expand Uro U.S. Clinical Trial Meets Safety and Effectiveness Primary Endpoints for Hugo™ Robotic-Assisted Surgery System

THOMSON REUTERS
·
27 Apr

Medtronic Plc - Study Achieves 98.5% Surgical Success Rate

THOMSON REUTERS
·
27 Apr

Medtronic (NYSE:MDT) Secures FDA Approval For Innovative OmniaSecure Defibrillation Lead

Simply Wall St.
·
27 Apr

Medtronic Receives FDA Approval For Small-Diameter Defibrillation Lead

Dow Jones
·
26 Apr

BRIEF-Medtronic Receives FDA Approval For Smallest-Diameter, Lumenless Defibrillation Lead, The Omniasecure Lead And Announces Investigational Clinical Study Results

Reuters
·
26 Apr

Myriad Genetics Highlights MRD Clinical Validity Data at American Association for Cancer Research Annual Meeting

GlobeNewswire
·
26 Apr

Tariffs Cast a Shadow on Abbott's 2025 View: Time to Sell ABT Stock?

Zacks
·
26 Apr

Medtronic Seeks FDA Marketing Approval for Interoperable Pump, SmartGuard Algorithm

MT Newswires Live
·
24 Apr

Medtronic Advances Abbott Cgm Partnership With FDA Submission of Interoperable Insulin Pump

THOMSON REUTERS
·
24 Apr

BRIEF-Medtronic Advances Abbott CGM Partnership With FDA Submission Of Interoperable Insulin Pump

Reuters
·
24 Apr